We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Healthcare | 14.47% |
| 3 | Technology | 14.27% |
| 4 | Communication Services | 9.94% |
| 5 | Consumer Staples | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNGT
1351
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $534K | ﹤0.01% |
20,091
+956
| +5% | +$25.4K |
|
|
AXON
1352
Axon Enterprise
AXON
$37.9B
| $530K | ﹤0.01% |
21,295
-754
| -3% | -$15.6K |
|
1353
Booz Allen Hamilton
BAH
$9.42B
| $530K | ﹤0.01% |
17,894
+3,281
| +22% | +$93.9K |
|
1354
ITT
ITT
$17.4B
| $530K | ﹤0.01% |
16,571
-1,358
| -8% | -$48.7K |
|
|
AUY
1355
DELISTED
Yamana Gold, Inc.
AUY
| $530K | ﹤0.01% |
101,841
+10,180
| +11% | +$45.7K |
|
1356
Enterprise Products Partners
EPD
$82.9B
| $529K | ﹤0.01% |
18,066
-16,847
| -48% | -$452K |
|
1357
Wabash National
WNC
$483M
| $529K | ﹤0.01% |
41,691
+919
| +2% | +$12.4K |
|
1358
Chesapeake Utilities
CPK
$3.12B
| $528K | ﹤0.01% |
7,983
-264
| -3% | -$15.9K |
|
1359
Neurocrine Biosciences
NBIX
$15.3B
| $523K | ﹤0.01% |
11,520
+2,114
| +22% | +$97.3K |
|
|
BCPC
1360
Balchem Corp
BCPC
$5.38B
| $523K | ﹤0.01% |
8,767
-252
| -3% | -$15.4K |
|
1361
PTC
PTC
$14.3B
| $521K | ﹤0.01% |
13,873
+1,591
| +13% | +$57K |
|
1362
Bruker
BRKR
$9.26B
| $520K | ﹤0.01% |
22,868
+789
| +4% | +$21.1K |
|
1363
Seaboard Corp
SEB
$4.17B
| $520K | ﹤0.01% |
181
-17
| -9% | -$49.9K |
|
1364
IPG Photonics
IPGP
$3.29B
| $519K | ﹤0.01% |
6,489
+1,084
| +20% | +$95.3K |
|
|
EGN
1365
DELISTED
Energen
EGN
| $516K | ﹤0.01% |
10,695
+969
| +10% | +$42.2K |
|
|
DYN
1366
DELISTED
Dynegy, Inc.
DYN
| $516K | ﹤0.01% |
29,923
+2,117
| +8% | +$36.8K |
|
1367
Encompass Health
EHC
$12.3B
| $513K | ﹤0.01% |
16,609
+1,319
| +9% | +$41.3K |
|
|
HI
1368
DELISTED
Hillenbrand
HI
| $512K | ﹤0.01% |
17,040
-401
| -2% | -$12.1K |
|
1369
Jack in the Box
JACK
$257M
| $511K | ﹤0.01% |
5,953
-2,195
| -27% | -$166K |
|
|
IDTI
1370
DELISTED
Integrated Device Technology I
IDTI
| $509K | ﹤0.01% |
25,285
-2,478
| -9% | -$52.4K |
|
|
RICE
1371
DELISTED
Rice Energy Inc.
RICE
| $509K | ﹤0.01% |
23,116
+113
| +0.5% | +$2.11K |
|
1372
Minerals Technologies
MTX
$2.14B
| $508K | ﹤0.01% |
8,941
+1,133
| +15% | +$65.7K |
|
|
DDC
1373
DELISTED
Dominion Diamond Corporation
DDC
| $508K | ﹤0.01% |
57,502
+11,309
| +24% | +$121K |
|
|
PEGI
1374
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $505K | ﹤0.01% |
21,976
+7,953
| +57% | +$165K |
|
1375
Ingevity
NGVT
$2.36B
| $504K | ﹤0.01% |
+14,817
| New | +$463K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.